Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-22-001319

Options or other derivatives

  • President and CEO acquired 182,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BEN-MAIMON CAROLE · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-18 Grant or award : show line 1 in the form Stock Option (Right to Buy) +182,000 182,000 D
Loading xslF345X03/form4.xml…